Neumora Therapeutics, Inc. Common Stock (NMRA) — Analyst estimates
Consensus analyst estimates for Neumora Therapeutics, Inc. Common Stock — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.18 | 4 |
| 2027 | 0 | -0.24 | 2 |
| 2028 | 53.63M | -0.76 | 7 |
| 2029 | 161.35M | -0.45 | 2 |
| 2030 | 355.47M | 0.08 | 5 |
Consensus analyst estimates by fiscal year.